Outcomes From Real-World Data on Intraoperative Electronic Radiotherapy for the Treatment of Early-Stage Breast Cancer: Long-Term Recurrence and Survival Outcomes From a Single Center

被引:0
|
作者
de la Mata, Dolores [1 ]
Santiago-Concha, Bernardino Gabriel [1 ]
Bargallo-Rocha, Juan Enrique [2 ]
Robles-Vidal, Carlos Daniel [2 ]
Gomez-Pue, Daniella [2 ]
Castorena-Roji, Gerardo [2 ]
Hinojosa-Gomez, Jose [1 ]
Flores-Vazquez, Fabiola [1 ]
Blake-Cerda, Monika [1 ]
Enriquez-Barrera, Mario [1 ]
Maffuz-Aziz, Antonio [2 ]
机构
[1] Ctr Med ABC, Dept Radiat Oncol, Mexico City, Mexico
[2] Ctr Med ABC, Dept Oncol Surg Gynecol Surg, Mexico City, Mexico
关键词
IORT; Lumpectomy; Mastectomy-free; Overall survival; Targeted radiotherapy; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; IRRADIATION; LUMPECTOMY; MASTECTOMY; TRIAL; ELIOT; NODE;
D O I
10.1155/2024/6207762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study is aimed at investigating the 10-year outcomes of intraoperative radiotherapy (IORT) in Mexican women with early breast cancer (EBC) treated at the Centro Medico ABC, Mexico City.Methods: A cohort study included women with early-stage invasive ductal carcinoma aged >= 45 years without prior oncologic treatment, tumor size <= 3.5 cm, cN0M0, positive hormone receptors, margins >= 2 mm, negative sentinel lymph nodes, and no extensive lymphovascular invasion. IORT was administered at 20 Gy for 20-30 min after a lumpectomy. Follow-up extended over 10 years and included clinical examinations every 6 months for the first 18 months, followed by annual mammograms and conventional examinations. Patients out of the criteria were excluded from this study because they were referred for additional surgery and/or whole-breast radiation therapy.Results: The study involved 238 patients with an average age of 61.1 years. The mean tumor size was 12 mm, and the percentages of lymphatic invasion, positive hormone receptors, and HER2/neu overexpression were 12.6%, 90.8%, and 2.1%, respectively. The median follow-up was 66.6 months (range: 1-126 months), and the overall survival and mastectomy-free rate reached 95.7% and 90%, respectively. Thirteen patients showed side effects; four recurrences were recorded, of which 50% were out-field relapses. The 5-year Kaplan-Meier probability of local relapses, mastectomy-free, and overall survival reached 97.5%, 100%, and 98%, respectively.Conclusions: This is the first 10-year report about the effect of IORT on Mexican women with EBC in the early stages. Strict adherence to the selection criteria in this study resulted in low rates of side effects, mortality, and local recurrences, demonstrating that IORT is an effective treatment alternative for patients with EBC. Studies with a longer follow-up period should be performed, as recurrences can occur in the long term.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Long-term clinical outcomes of Lenvatinib in patients with differentiated thyroid cancer: Results from the real-world practice of a single institution
    Onaga, R.
    Enokida, T.
    Okano, S.
    Fujisawa, T.
    Tanaka, H.
    Takeshita, N.
    Tanaka, N.
    Hoshi, Y.
    Tahara, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1147 - S1147
  • [42] Local Recurrence Outcomes in Phase II Clinical Trial Using Single Dose Intraoperative Radiotherapy (IORT) before Surgical Excision of Early-stage Breast Cancer
    VanderWalde, N. A.
    Ollila, D. W.
    DeMore, N. K.
    Moore, D. T.
    Kimple, R. J.
    Kuzmiak, C. M.
    Pavic, D.
    Sartor, C. I.
    Lian, J.
    Jones, E. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S10 - S11
  • [43] Real-world outcomes of neoadjuvant chemotherapy for breast cancer: Reflections from a community cancer center.
    Bhardwaj, Prarthna V.
    Kaufman, Seth
    Mason, Holly
    Visintainer, Paul
    Makari-Judson, Grace
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18690 - E18690
  • [44] REAL-WORLD TRENDS IN LONG-TERM CLINICAL OUTCOMES OF LUMACAFTOR/IVACAFTOR TREATMENT
    Muilwijk, D.
    Zomer, D.
    Gulmans, V
    van der Ent, K.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S99 - S99
  • [45] Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution
    Marta Sotelo
    Nerea Muñoz-Unceta
    Antonio Matorras
    Pablo Jara
    Clara Castro
    Diego Cacho
    Belén Caramelo
    Ainara Azueta
    Ignacio Durán
    Clinical and Translational Oncology, 2024, 26 : 682 - 688
  • [46] Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution
    Sotelo, Marta
    Munoz-Unceta, Nerea
    Matorras, Antonio
    Jara, Pablo
    Castro, Clara
    Cacho, Diego
    Caramelo, Belen
    Azueta, Ainara
    Duran, Ignacio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (03): : 682 - 688
  • [47] Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
    Inna Y. Gong
    Sunil Verma
    Andrew T. Yan
    Dennis T. Ko
    Craig C. Earle
    George A. Tomlinson
    Maureen E. Trudeau
    Murray D. Krahn
    Monika K. Krzyzanowska
    Christine B. Brezden-Masley
    Scott Gavura
    Stuart Peacock
    Kelvin K. W. Chan
    Breast Cancer Research and Treatment, 2016, 157 : 535 - 544
  • [48] Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study
    Gong, Inna Y.
    Verma, Sunil
    Yan, Andrew T.
    Ko, Dennis T.
    Earle, Craig C.
    Tomlinson, George A.
    Trudeau, Maureen E.
    Krahn, Murray D.
    Krzyzanowska, Monika K.
    Brezden-Masley, Christine B.
    Gavura, Scott
    Peacock, Stuart
    Chan, Kelvin K. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 535 - 544
  • [49] Laparoscopic radical surgery in early-stage cervical cancer: short-term and long-term outcomes and survival analysis
    He, Hongying
    Yang, Zhijun
    Zhang, Jieqing
    Yao, Desheng
    Fan, Jiangtao
    Zhao, Renfeng
    Zeng, Dingyuan
    Hu, Xiaoxia
    Lin, Zhong
    Wang, He
    Pan, Zhongmian
    Jiang, Yanming
    Li, Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 12044 - 12055
  • [50] Long-term survival outcomes with regular recurrence surveillance following surgical resection in early-stage hepatocellular carcinoma: Insights from a multicenter prospective study
    Yang, Tian
    Yao, Lan-Qing
    Liu, Han
    Diao, Yong-Kang
    Wu, Yi-Fan
    Li, Chao
    Liang, Ying-Jian
    Zeng, Yong-Yi
    Wang, Ming-Da
    Shen, Feng
    Lv, Guo-Yue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)